​

Funding Round

Venture Round - MyoKardia

Venture Round - MyoKardia

Investment Firm

Overview

MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.

Announced Date

Aug 22, 2014

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorCormorant Asset Management
Participant InvestorCowen Group
Participant InvestorSanofi
Participant InvestorBridgeBio
Participant InvestorThird Rock Ventures

Round Details and Background

MyoKardia raised $10000000 on 2014-08-22 in Venture Round

MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 30, 2015
Series B - MyoKardia
5-46.0M
Aug 22, 2014
Venture Round - MyoKardia
6-10.0M
Oct 04, 2012
Venture Round - MyoKardia
-4.0M
Sep 20, 2012
Series A - MyoKardia
1-38.0M

Recent Activity

There is no recent news or activity for this profile.